Bacitracin

{{drugbox | IUPAC_name = (4R)-4-[(2S)-2-({2-[(1S)-1-amino-2-methylbutyl]- 4,5-dihydro-1,3-thiazol-5-yl}formamido)-4-methylpentanamido]-4-{[(1S)- 1-{[(3S,6R,9S,12R,15S,18R,21S)- 18-(3-aminopropyl)-12-benzyl-15-(butan-2-yl)-3-(carbamoylmethyl)- 6-(carboxymethyl)-9-(1H-imidazol-5-ylmethyl)-2,5,8,11,14,17,20- heptaoxo-1,4,7,10,13,16,19-heptaazacyclopentacosan-21-yl]carbamoyl}- 2-methylbutyl]carbamoyl}butanoic acid | image = Bacitracin A.svg.png | CAS_number = 1405-87-4 | ATC_prefix = D06 | ATC_suffix = AX05 | ATC_supplemental = R02AB04 (WHO) | PubChem = 439542 | DrugBank = APRD00816 | C = 66 | H = 103 | N = 17 | O = 16 | S = 1 | molecular_weight = 1422.69 g/mol | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | pregnancy_category = | legal_status = OTC/℞-only | routes_of_administration = Topical, intramuscular }}

WikiDoc Resources for Bacitracin
Articles
Most recent articles on Bacitracin Most cited articles on Bacitracin Review articles on Bacitracin Articles on Bacitracin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Bacitracin Images of Bacitracin Photos of Bacitracin Podcasts & MP3s on Bacitracin Videos on Bacitracin
Evidence Based Medicine
Cochrane Collaboration on Bacitracin Bandolier on Bacitracin TRIP on Bacitracin
Clinical Trials
Ongoing Trials on Bacitracin at Clinical Trials.gov Trial results on Bacitracin Clinical Trials on Bacitracin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Bacitracin NICE Guidance on Bacitracin NHS PRODIGY Guidance FDA on Bacitracin CDC on Bacitracin
Books
Books on Bacitracin
News
Bacitracin in the news Be alerted to news on Bacitracin News trends on Bacitracin
Commentary
Blogs on Bacitracin
Definitions
Definitions of Bacitracin
Patient Resources / Community
Patient resources on Bacitracin Discussion groups on Bacitracin Patient Handouts on Bacitracin Directions to Hospitals Treating Bacitracin Risk calculators and risk factors for Bacitracin
Healthcare Provider Resources
Symptoms of Bacitracin Causes & Risk Factors for Bacitracin Diagnostic studies for Bacitracin Treatment of Bacitracin
Continuing Medical Education (CME)
CME Programs on Bacitracin
International
Bacitracin en Espanol Bacitracin en Francais
Business
Bacitracin in the Marketplace Patents on Bacitracin
Experimental / Informatics
List of terms related to Bacitracin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Bacitracin is a mixture of related cyclic polypeptides produced by organisms of the licheniformis group of Bacillus subtilis var Tracy. Its unique name derives from the fact that the bacillus producing it was first isolated in 1943 from a knee scrape from a girl named Margaret Tracy. As a toxic and difficult-to-use antibiotic, bacitracin doesn't work well orally. However, it is very effective topically.

Bacitracin is synthesised via the so-called nonribosomal peptide synthetases (NRPSs), which means that ribosomes are not involved in its synthesis.

Mechanism of action

Bacitracin interferes with the dephosphorylation of the C₅₅-isoprenyl pyrophosphate, a molecule which carries the building blocks of the peptidoglycan bacterial cell wall outside of the inner membrane [3].

Clinical use

Bacitracin is used in human medicine and is "approved by the FDA for use in chickens and turkeys."

As bacitracin zinc salt, and in combination with other topical antibiotics (usually polymyxin B and neomycin), it is used in ointment form for topical treatment of a variety of localized skin and eye infections, as well as for the prevention of wound infections. In the United States a popular brand name Neosporin contains Bacitracin as one of its antibiotic agents along with Neomycin and Polymyxin B. Bacitracin can also be bought in pure form for those with allergies.

It is also commonly used as an aftercare antibiotic on tattoos. It is preferred over Neosporin because of its fewer ingredients, which lowers chances of an allergic reaction.

In infants, it is sometimes administered intramuscularly for the treatment of pneumonias. This formulation is sold under the brand name Baciim®.

References

Template:PolypeptideAntiBiotics Template:Throat preparations Template:SIB